Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2017.07.05
关于妄想刊行股份购置资产的停牌希望通告
2017.07.05
第四届董事会第三次聚会决议通告
2017.07.05
关于拟使用闲置召募资金购置银行保本理工业品的通告
2017.06.29
公司债券2017年跟踪评级报告
2017.06.28
关于妄想刊行股份购置资产的停牌希望通告
2017.06.28
关于公司与汇丰银行交织钱币掉期生意平仓的通告
2017.06.24
关于签署《召募资金三方羁系协议》的通告
2017.06.21
2016年年度权益分派实验通告
2017.06.21
关于妄想刊行股份购置资产停牌希望及继续停牌通告
2017.06.21
第四届董事会第二次聚会决议通告
第一页
上一页
71
72
73
74
75
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】